Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05692830 · ClinicalTrials.gov registry record
Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms
A clinical trial of Alcohol Drinking and Alcohol Intoxication, sponsored by University of Illinois at Urbana-Champaign.
- Recruiting
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT05692830 is a study of Alcohol Drinking and Alcohol Intoxication that is actively recruiting participants, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 240 participants, below the 628-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05692830, a study of Alcohol Drinking and Alcohol Intoxication, is actively recruiting participants, sponsored by University of Illinois at Urbana-Champaign.
- RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will employ a combined laboratory-ambulatory design. Participants will engage in ambulatory assessment over the course of 14 days, wearing biosensors assessing transdermal alcohol concentration (TAC) and providing breathalyzer readings in real-world contexts. Also during this period, participants will attend three laboratory alcohol-administration sessions scheduled at one-week intervals, with alcohol dose and rate of consumption manipulated within and between participants, respectively. Laboratory visits will also double as ambulatory orientation, check-in, and close-out sessions.
Conditions Studied
Interventions
- DRUG Alcohol
Study Locations (1)
Illinois
- University of Illinois at Urbana-Champaign - Champaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2022-10-22 |
| Est. Completion | 2027-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05692830
The ClinicalTrials.gov registry entry for NCT05692830 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 628-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (62% lower). The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Alcohol is the first listed.
NCT05692830 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05692830 about?
NCT05692830 is a clinical study titled "Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms". The study will employ a combined laboratory-ambulatory design. Participants will engage in ambulatory assessment over the course of 14 days, wearing biosensors assessing transdermal alcohol concentration (TAC) and providing breathalyzer readings in real-world contexts. Also during this period, parti...
What is the current status of trial NCT05692830?
This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2022-10-22. Estimated completion is 2027-09-01.
What conditions does trial NCT05692830 study?
This clinical trial studies the following conditions: Alcohol Drinking, Alcohol Intoxication.
What interventions are being tested in trial NCT05692830?
The interventions under investigation include: Alcohol (DRUG).
Who is sponsoring clinical trial NCT05692830?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05692830 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Nicotinic Receptor Genetic Variation and Alcohol Reward
RECRUITING · Phase 1
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.